Chemotherapy Followed by Infusion of Partially HLA Matched Unrelated Donor Cells for Patients With AML Who Are Ineligible for Stem Cell Transplantation

NCT02189824 · clinicaltrials.gov ↗
PHASE1
Phase
UNKNOWN
Status
12
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

University of Sydney

Collaborators